<DOC>
	<DOCNO>NCT01572818</DOCNO>
	<brief_summary>The purpose study evaluate efficacy phlebotomy insulin sensitivity evaluate euglycemic-hyperinsulinic clamp insulin resistance-associated hepatic iron overload patient .</brief_summary>
	<brief_title>Effects Phlebotomy Insulin Sensitivity Insulin Resistance-associated Hepatic Iron Overload Patients</brief_title>
	<detailed_description>The main objective study evaluate patient HSD effect treatment phlebotomy rule lifestyle dietary rule versus lifestyle modification alone peripheral insulin resistance ( assessed hyperinsulinemic clamp ) . Secondary objective : - study patient HSD relationship amount iron intrahepatic degree peripheral insulin resistance liver therapeutic intervention . - study compare effect phlebotomy treatment versus treatment : - Plasma level adipocytokines , - Plasma concentration inflammatory marker marker insulin resistance , - The serum ferritin , - The post-hepatic clearance insulin , - The surface abdominal visceral fat subcutaneous abdominal .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Iron Overload</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Age 18 70 year Ferritin 450 1000 µg/L Hepatic iron overload prove MRI ( CHF &gt; 36 µmol/g ) Body mass index &gt; 25 kg/m² Fasting glycemia &lt; 1,26 g/L HbA1c &lt; 6,5 % Signed write informed consent Other cause hyperferritinemia : Inflammatory syndrome ( CRP &gt; 10 mg/L ) inflammatory , immune malignant disease Hyperferritinemiacataract syndrome ( familial cataract personal history cataract 50 year old ) Low ceruloplasmin level Porphyria ( cutaneous sign ) Haemochromatosis establish genotype ( C282Y homozygous C282Y/H63D coumpound heterozygous genotype ) Contraindication phlebotomy Haemoglobin &lt; 13,5 g/dL ( threshold establish Etablissement Français du Sang ) Heart failure coronary heart diseases Hepatic failure , renal ( GFR &lt; 50mL/min ) respiratory insufficiency ( chronic dyspnea ) Poor venous system Viral , immune , genetic , vascular , malignant toxic chronic hepatic disease Alcohol consumption 21 dos per week 5 year Type 1 type 2 diabetes Oral antidiabetic , corticoid immune suppressor drug Hepatic severe disease Claustrophobia , pacemaker intracerebral clip Subjects deprive liberty judicial administrative decision , subject affiliate social security topic exclusion period previous study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Phlebotomy</keyword>
	<keyword>Insulin Resistance</keyword>
	<keyword>Iron Overload</keyword>
</DOC>